Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis

Matteo Ravaioli, Gian Luca Grazi, Alfonso Principe, Giorgio Ercolani, Matteo Cescon, Andrea Gardini, Giovanni Varotti, Massimo Del Gaudio, Antonino Cavallari

Research output: Contribution to journalArticlepeer-review


Background/Aims: The purpose of this study was to evaluate the clinical usefulness of the preoperative lidocaine test (MEGX) in cirrhotic patients who were candidates for curative liver resection for hepatocellular carcinoma. Methodology: To evaluate whether MEGX was related to postoperative complications, a retrospective analysis was carried out on 51 patients, in whom a preoperative lidocaine test was available. They were divided into two groups according to a MEGX value less (22 patients, group A) or more (29 patients, group B) than 25ng/mL. Results: The two groups of patients were comparable for the preoperative clinical parameters and the surgical procedures. Patients in group A had a significantly higher rate of postoperative complications (73% vs. 28%, p

Original languageEnglish
Pages (from-to)1552-1555
Number of pages4
Issue number53
Publication statusPublished - Sept 2003


  • Cirrhosis
  • Hepatic resection
  • Hepatocellular carcinoma
  • Lidocaine test
  • Liver function
  • MEGX
  • Postoperative complications

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis'. Together they form a unique fingerprint.

Cite this